Skip to content

Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With Insomnia

Sleep-4-all-2.0 Study: Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With Insomnia - A Prospective Real-life Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05977062
Acronym
Sleep-4-All-2
Enrollment
348
Registered
2023-08-04
Start date
2022-02-25
Completion date
2025-07-08
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Insomnia

Brief summary

Determine who can benefit from additional follow-up by a professional and what type of help is most appropriate (need and expectation of patients in terms of support by a health professional)

Interventions

OTHERSelf screening

Score ISI (Index de Sévérité de l'Insomnie)

OTHERPhone call

Phone call at the beginning of the program and at the middle and at the end.

To be completed at week 1, 6, 12 and 24.

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults patients, * With a diagnosis of localized or metastatic cancer, * During or after their treatment, * In one of the following three cancer centres: Gustave Roussy (Villejuif), Montpellier Cancer Institute (Montpellier), and Léon Bérard Center (Lyon) * With a significative score on the self-screening Insomnia Severity Index score (ISI ≥ 8) * Able to readily read and understand French, * Able to use informatic tools confidently and with Internet access, * Who have signed the online consent form, * Affiliated to a social security system or beneficiary of the same.

Exclusion criteria

* Patient with a visual, hearing or cognitive disability that is incompatible with the study, * Simultaneous participation in another study evaluating a treatment of insomnia, * Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.

Design outcomes

Primary

MeasureTime frameDescription
Evolution of the ISI scoreuntil 24 weeks after enrolmentThe primary outcome is to evaluate the evolution of the ISI score of patients with score \> 8. ISI = Index de Sévérité de l'Insomnie. Score \> 8 means the patient has insomnia issue.
Patient insomnia perceptionuntil 24 weeks after enrolmentTwo ad-hoc items will be proposed to the participants to determine if insomnia is considered as a problem for them (outcome perception), and as a problem important to solve (outcome expectancy).
Adherence to the interventionuntil 24 weeks after enrolmentThe frequency and the evolution of connections (A/globally, namely total number of connections per week and during all the intervention; B/potential differences in the frequency of connections throughout the weeks); * the type and proportion of components effectively consulted (videos, modules, and tools); * the duration of the use of the study web platform (total number of weeks).

Countries

France

Contacts

STUDY_CHAIRDiane BOINON, MD

Gustave Roussy, Cancer Campus, Grand Paris

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026